Not so NICE for mifamurtide

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.608, 2010-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does `NICE blight' exist, and if so, why?

By Haycox Alan

PharmacoEconomics, Vol. 26, Iss. 12, 2008-01 ,pp. : 987-989

Adis International

Access to resources Recommend Favorite

NICE not so bad after all?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 561, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Mifamurtide for the treatment of nonmetastatic osteosarcoma

By Ando Kosei Mori Kanji Corradini Nedège Redini Françoise Heymann Dominique

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 285-292

Informa Healthcare

Access to resources Recommend Favorite

Mifamurtide boosts chemo efficacy in osteosarcoma

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Mifamurtide receives positive opinion in Europe.

Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite